3 ms·
Considering that the average new molecular entity requires about $1 billion dollars over 10 years (factoring in cost of refining approximately 10,000 candidates
by criley2 11y ago
Considering that the average new molecular entity requires about $1 billion dollars over 10 years (factoring in cost of refining approximately 10,000 candidates into 1 entity capable of succeeding in Phased trials and receive approval), I'm not so sure these startups are anywhere near the "pharma" level.
- ThomPete 11y agoIt's more the perspective. I.e. you can't just apply tech to healthcare and expect to become successful anymore than you can apply it to ex. the shipping industry. Some businesses are so intertwined with everything from unions, to legality to human behavior that you need to know what you are getting into before you even start.